{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Borges S"],"funding":["Health Sciences Teaching and Research Foundation’s","Research Support Foundation","Health Sciences Teaching and Research Foundation's"],"pagination":["23262"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11456598"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["This study aimed to evaluate the association between the questionnaires SARC-F and SARC-CalF with risk of mortality in patients undergoing hemodialysis (HD). A cohort study, with patients on HD age ≥ 18 years, both sex, between June 2019 and April 2023. Body composition (anthropometry and bioelectrical impedance), muscle functional (handgrip strength and gait speed), screening of sarcopenia using the SARC-F and SARC-CalF, nutritional status and laboratory data were assessed. Follow-up for mortality up to 47 months. The sample consisted of 243 participants and the prevalence of risk of sarcopenia using SARC-F and SARC-CalF were 30% and 45%, respectively; 65 died for all reasons and three patients were censored due to transplantation. Multivariate analysis identified SARC-CalF as predictor o"],"journal":["Scientific reports"],"pubmed_title":["Performance of SARC-F and SARC-CalF scores to predict risk of mortality in hemodialysis patients: a cohort study."],"pmcid":["PMC11456598"],"funding_grant_id":["grant numbers 03, 2023","grant numbers 06, 2020"],"pubmed_authors":["Ferreira Martins T","Cipriano G","Borges S","Lopes Alves M","Fortes RC","Franca Bernardelli Cipriano G"],"additional_accession":[]},"is_claimable":false,"name":"Performance of SARC-F and SARC-CalF scores to predict risk of mortality in hemodialysis patients: a cohort study.","description":"This study aimed to evaluate the association between the questionnaires SARC-F and SARC-CalF with risk of mortality in patients undergoing hemodialysis (HD). A cohort study, with patients on HD age ≥ 18 years, both sex, between June 2019 and April 2023. Body composition (anthropometry and bioelectrical impedance), muscle functional (handgrip strength and gait speed), screening of sarcopenia using the SARC-F and SARC-CalF, nutritional status and laboratory data were assessed. Follow-up for mortality up to 47 months. The sample consisted of 243 participants and the prevalence of risk of sarcopenia using SARC-F and SARC-CalF were 30% and 45%, respectively; 65 died for all reasons and three patients were censored due to transplantation. Multivariate analysis identified SARC-CalF as predictor o","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2026-06-07T07:39:18.103Z","creation":"2025-04-04T01:54:35.292Z"},"accession":"S-EPMC11456598","cross_references":{"pubmed":["39370431"],"doi":["10.1038/s41598-024-74412-6"]}}